The School of Public Health and Health Sciences has awarded seventeen Dean’s PhD Summer Fellowships for summer 2018. The $7000 awards will provide support for PhD students in excellent standing to pursue their research and complete their dissertations during the summer months.
The School of Public Health and Health Sciences will host a special Boston Alumni Night on Monday, June 25, 2018, from 6:00-8:00 p.m. at The University of Massachusetts Club.
Biostatistics doctoral student Stephen Lauer is the lead author of a paper published in the Proceedings of the National Academy of Sciences (PNAS). Titled “Prospective forecasts of annual dengue hemorrhagic fever incidence in Thailand, 2010-2014,” the article presents findings on dengue hemorrhagic fever prediction forecasting models tested over the course of a five-year period.
A group of more than two dozen undergraduate and graduate students attended this year’s SPHHS Awards Celebration, where they were recognized for outstanding achievements in the classroom, in research, and through service to the community. The SPHHS Awards Celebration was held in the Old Chapel on April 28, 2018.
The SPHHS is pleased to announce the 2018 SPHHS Research Day award winners: Aastha Pokharel (1st place), Stephanie Hung (2nd place), Carl Jewell (3rd place), and Joshua Freeman and CHristine Langton (Honorable Mentions). Haydee Jacobs was named the Delta Omega abstract winner.
The departments of Biostatistics and Epidemiology and Mathematics and Statistics at the University of Massachusetts Amherst are co-hosting the 32nd annual New England Statistics Symposium in the UMass Amherst Campus Center on April 13-14. The symposium brings together statisticians from across New England to share research, discuss emerging issues in the field, and network with colleagues.
Nicholas Reich, Associate Professor of Biostatistics, recently announced the creation of a new “global forum for disease forecasting and surveillance research” available through the Open Access publisher Public Library of Science (PLOS).
India has one of the highest rates of type 2 diabetes in the world, and there is now “growing national and international concern” about the drug regulatory system there, which allows use of a drug treatment that has not been shown effective or safe, say researchers at UMass Amherst and the U.K.’s Newcastle University in a paper recently published in the British Medical Journal.
- 2 of 2